HAE-话题@MedSci

#HAE#

411篇内容 | 2296人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2008499, encodeId=efcc2008499ba, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤, objectType=article, longId=206006, objectId=dea22060068e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dea22060068e, replyNumber=0, likeNumber=59, createdTime=2021-10-15, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dea22060068e, moduleTitle=Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dea22060068e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008464, encodeId=0a1d200846492, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：严重COVID‐19患者抗凝治疗与死亡率降低有关, objectType=article, longId=191069, objectId=86461910697e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86461910697e, replyNumber=0, likeNumber=83, createdTime=2020-12-25, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86461910697e, moduleTitle=J Thromb Haemost：严重COVID‐19患者抗凝治疗与死亡率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86461910697e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008485, encodeId=3a1d2008485d6, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, objectType=article, longId=201580, objectId=a894201580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a894201580eb, replyNumber=0, likeNumber=74, createdTime=2021-02-11, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a894201580eb, moduleTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a894201580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008465, encodeId=35262008465b2, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性 , objectType=article, longId=191574, objectId=045e1915e4d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=045e1915e4d7, replyNumber=0, likeNumber=60, createdTime=2020-10-23, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=045e1915e4d7, moduleTitle=J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=045e1915e4d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008471, encodeId=271f20084e13b, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haematol：新型靶向药是否可取代自体造血干细胞移植？, objectType=article, longId=193394, objectId=5043193394ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5043193394ef, replyNumber=0, likeNumber=98, createdTime=2021-01-16, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5043193394ef, moduleTitle=Lancet haematol：新型靶向药是否可取代自体造血干细胞移植？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5043193394ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008459, encodeId=b13220084591d, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展, objectType=article, longId=189131, objectId=df8e18913157, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df8e18913157, replyNumber=0, likeNumber=70, createdTime=2021-01-28, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df8e18913157, moduleTitle=Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df8e18913157)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008483, encodeId=8bbb20084838c, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, objectType=article, longId=200385, objectId=776020038565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=776020038565, replyNumber=0, likeNumber=57, createdTime=2021-07-23, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776020038565, moduleTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776020038565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008466, encodeId=c531200846655, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, objectType=article, longId=192508, objectId=a0bb192508e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0bb192508e2, replyNumber=0, likeNumber=60, createdTime=2021-03-05, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0bb192508e2, moduleTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0bb192508e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008488, encodeId=30ac2008488fc, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：抗磷脂综合症患者利伐沙班疗效分析, objectType=article, longId=202802, objectId=9e38202802d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e38202802d3, replyNumber=0, likeNumber=59, createdTime=2021-01-15, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e38202802d3, moduleTitle=J Thromb Haemost：抗磷脂综合症患者利伐沙班疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e38202802d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008476, encodeId=28ca20084e6d1, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后, objectType=article, longId=197464, objectId=d1d819e4644b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d819e4644b, replyNumber=0, likeNumber=74, createdTime=2021-02-27, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d819e4644b, moduleTitle=Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d819e4644b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008479, encodeId=20c120084e9a4, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：苯二氮卓受体激动剂与静脉血栓栓塞风险, objectType=article, longId=198915, objectId=5a74198915a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a74198915a1, replyNumber=0, likeNumber=63, createdTime=2021-01-11, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a74198915a1, moduleTitle=J Thromb Haemost：苯二氮卓受体激动剂与静脉血栓栓塞风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a74198915a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008467, encodeId=7f26200846e4f, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：D-二聚体水平预测Covid‐19患者住院死亡率, objectType=article, longId=192632, objectId=6a201926328e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a201926328e, replyNumber=0, likeNumber=69, createdTime=2020-07-02, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a201926328e, moduleTitle=J Thromb Haemost：D-二聚体水平预测Covid‐19患者住院死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a201926328e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008468, encodeId=72522008468ae, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：首次心肌梗死住院后静脉血栓栓塞的合并症和风险 , objectType=article, longId=192822, objectId=72961928228b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72961928228b, replyNumber=0, likeNumber=72, createdTime=2021-01-04, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72961928228b, moduleTitle=J Thromb Haemost：首次心肌梗死住院后静脉血栓栓塞的合并症和风险 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72961928228b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008462, encodeId=81ec20084628e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：产前XIII因子活性对产后失血量的影响, objectType=article, longId=190227, objectId=bfd419022edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfd419022edc, replyNumber=0, likeNumber=58, createdTime=2021-02-03, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfd419022edc, moduleTitle=J Thromb Haemost：产前XIII因子活性对产后失血量的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfd419022edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008452, encodeId=affc200845259, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：症状性远端深静脉血栓形成后血栓后综合症的长期风险, objectType=article, longId=185700, objectId=31f3185e0030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31f3185e0030, replyNumber=0, likeNumber=64, createdTime=2020-12-11, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31f3185e0030, moduleTitle=J Thromb Haemost：症状性远端深静脉血栓形成后血栓后综合症的长期风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31f3185e0030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008477, encodeId=963220084e776, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：五种血栓形成基因型和癌症对首次静脉血栓栓塞事件风险的综合影响, objectType=article, longId=197774, objectId=823a19e7741e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823a19e7741e, replyNumber=0, likeNumber=67, createdTime=2020-11-17, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823a19e7741e, moduleTitle=J Thromb Haemost：五种血栓形成基因型和癌症对首次静脉血栓栓塞事件风险的综合影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823a19e7741e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008478, encodeId=6a6f20084e881, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤, objectType=article, longId=198711, objectId=97c8198e11f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c8198e11f4, replyNumber=0, likeNumber=79, createdTime=2021-03-24, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c8198e11f4, moduleTitle=Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c8198e11f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008450, encodeId=e3632008450ae, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症, objectType=article, longId=185329, objectId=0ab6185329f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ab6185329f3, replyNumber=0, likeNumber=86, createdTime=2020-09-23, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ab6185329f3, moduleTitle=Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ab6185329f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008457, encodeId=37f2200845ecc, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义, objectType=article, longId=188113, objectId=60e418811305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e418811305, replyNumber=0, likeNumber=96, createdTime=2020-08-31, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e418811305, moduleTitle=J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e418811305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008446, encodeId=61d22008446aa, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：3期试验：利伐沙班治疗静脉血栓栓塞儿童的临床预后和安全性, objectType=article, longId=182776, objectId=6513182e7613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6513182e7613, replyNumber=0, likeNumber=76, createdTime=2020-05-21, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6513182e7613, moduleTitle=Lancet haemat：3期试验：利伐沙班治疗静脉血栓栓塞儿童的临床预后和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6513182e7613)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HAE

2020-05-29

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤

2021-10-15

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：严重COVID‐19患者抗凝治疗与死亡率降低有关

2020-12-25

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效

2021-02-11

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性

2020-10-23

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haematol：新型靶向药是否可取代自体造血干细胞移植？

2021-01-16

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展

2021-01-28

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效

2021-07-23

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系

2021-03-05

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：抗磷脂综合症患者利伐沙班疗效分析

2021-01-15

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后

2021-02-27

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：苯二氮卓受体激动剂与静脉血栓栓塞风险

2021-01-11

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：D-二聚体水平预测Covid‐19患者住院死亡率

2020-07-02

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：首次心肌梗死住院后静脉血栓栓塞的合并症和风险

2021-01-04

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：产前XIII因子活性对产后失血量的影响

2021-02-03

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：症状性远端深静脉血栓形成后血栓后综合症的长期风险

2020-12-11

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：五种血栓形成基因型和癌症对首次静脉血栓栓塞事件风险的综合影响

2020-11-17

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤

2021-03-24

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症

2020-09-23

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义

2020-08-31

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：3期试验：利伐沙班治疗静脉血栓栓塞儿童的临床预后和安全性

2020-05-21

科室
- - 订阅+
  - 更多科室
工具
服务